Role of sleep quality in the metabolic syndrome

Diabetes, Metabolic Syndrome and Obesity

Volumn 9, Issue , 2016, Pages 281-310

  Koren, Dorit ^a,b   Dumin, Magdalena ^a   Gozal, David ^b,c  

^a UNIVERSITY OF CHICAGO   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

^c UNIVERSITY OF CHICAGO   (United States)

Author keywords

Cardiovascular risk; Circadian clock; Insulin resistance; Obesity; Sleep apnea

Indexed keywords

ANDROGEN; GLUCOSE; INSULIN;

ADULTHOOD; ALL CAUSE MORTALITY; ARTERIAL STIFFNESS; ATHEROSCLEROSIS; CARDIOMETABOLIC RISK; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CHILDHOOD; CIRCADIAN RHYTHM; CIRCADIAN RHYTHM SLEEP DISORDER; DISEASE ASSOCIATION; DISEASE MODEL; DISEASE PREDISPOSITION; DYSLIPIDEMIA; ENDOTHELIAL DYSFUNCTION; EVIDENCE BASED PRACTICE; GLUCOSE HOMEOSTASIS; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIFESPAN; METABOLIC REGULATION; METABOLIC SYNDROME X; MORBIDITY; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PANCREAS ISLET BETA CELL; PANCREAS ISLET CELL FUNCTION; PATHOPHYSIOLOGY; PREPUBERTY; REVIEW; RISK ASSESSMENT; SEX DIFFERENCE; SLEEP DEPRIVATION; SLEEP DISORDERED BREATHING; SLEEP QUALITY; SLEEP TIME;

EID: 84991780888     PISSN: None     EISSN: 11787007     Source Type: Journal    
DOI: 10.2147/DMSO.S95120     Document Type: Review

References (451)

1. Flegal KM, Carroll MD, Kit BK, Ogden CL. Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010. JAMA. 2012;307(5):491–497.
2. Ng M, Fleming T, Robinson M, et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2014;384(9945):766–781.
3. Ogden CL, Carroll MD, Kit BK, Flegal KM. Prevalence of childhood and adult obesity in the United States, 2011-2012. JAMA. 2014;311(8):806–814.
4. Hannon TS, Rao G, Arslanian SA. Childhood obesity and type 2 diabetes mellitus. Pediatrics. 2005;116(2):473–480.
5. Rocchini AP. Childhood obesity and a diabetes epidemic. N Engl J Med. 2002;346(11):854–855.
6. Morrison JA, Friedman LA, Wang P, Glueck CJ. Metabolic syndrome in childhood predicts adult metabolic syndrome and type 2 diabetes mellitus 25 to 30 years later. J Pediatr. 2008;152(2):201–206.
7. Morrison JA, Friedman LA, Gray-McGuire C. Metabolic syndrome in childhood predicts adult cardiovascular disease 25 years later: the Princeton lipid research clinics follow-up study. Pediatrics. 2007;120(2):340–345.
8. Yudkin JS. Insulin resistance and the metabolic syndrome – or the pitfalls of epidemiology. Diabetologia. 2007;50(8):1576–1586.
9. Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes. 1988;37(12):1595–1607.
10. Aguilar M, Bhuket T, Torres S, Liu B, Wong RJ. Prevalence of the metabolic syndrome in the United States, 2003-2012. JAMA. 2015;313(19):1973–1974.
11. Cook S, Weitzman M, Auinger P, Nguyen M, Dietz WH. Prevalence of a metabolic syndrome phenotype in adolescents: findings from the third National Health and Nutrition Examination Survey, 1988-1994. Arch Pediatr Adolesc Med. 2003;157(8):821–827.
12. Johnson WD, Kroon JJ, Greenway FL, Bouchard C, Ryan D, Katzmarzyk PT. Prevalence of risk factors for metabolic syndrome in adolescents: National Health and Nutrition Examination Survey (NHANES), 2001-2006. Arch Pediatr Adolesc Med. 2009;163(4):371–377.
13. Zimmet P, Alberti G, Kaufman F, et al. The metabolic syndrome in children and adolescents. Lancet. 2007;369(9579):2059–2061.
14. Ahrens W, Moreno LA, Marild S, et al; IDEFICS Consortium. Metabolic syndrome in young children: definitions and results of the IDEFICS study. Int J Obes. 2014;38(S2):S4–S14.
15. Weiss R. Childhood metabolic syndrome: must we define it to deal with it? Diabetes Care. 2011;34(suppl 2):S171–S176.
16. Weiss R, Dziura J, Burgert TS, et al. Obesity and the metabolic syndrome in children and adolescents. N Engl J Med. 2004;350(23): 2362–2374.
17. de Ferranti SD, Gauvreau K, Ludwig DS, Neufeld EJ, Newburger JW, Rifai N. Prevalence of the metabolic syndrome in American adolescents: findings from the third national health and nutrition examination survey. Circulation. 2004;110(16):2494–2497.
18. Dhuper S, Cohen HW, Daniel J, et al. Utility of the modified ATP III defined metabolic syndrome and severe obesity as predictors of insulin resistance in overweight children and adolescents: a cross-sectional study. Cardiovasc Diabetol. 2007;6:4.
19. Epstein LH, Myers MD, Raynor HA, Saelens BE. Treatment of pediatric obesity. Pediatrics. 1998;101(3 pt 2):554–570.
20. CDC [webpage on the Internet]. Insufficient sleep is a public health problem. CDC features: data and statistics 2015. Available from: http://www.cdc.gov/features/dssleep/. Accessed April 13, 2016.
21. Liu Y, Wheaton AG, Chapman DP, Cunningham TJ, Lu H, Croft JB. Prevalence of healthy sleep duration among adults – United States, 2014. MMWR Morb Mortal Wkly Rep. 2016;65(6):137–141.
22. National Sleep Foundation [webpage on the Internet]. 2004 Sleep in America Poll. Sleep in America 2004. Available from: https://sleepfoundation.org/sites/default/files/FINAL%20SOF%202004.pdf. Accessed April 13, 2016.
23. National Sleep Foundation [webpage on the Internet]. 2006 Sleep in America Poll; 2006. Available from: http://sleepfoundation.org/sites/default/files/2006_summary_of_findings.pdf. Accessed August 3, 2014.
24. Buxton OM, Chang A-M, Spilsbury JC, Bos T, Emsellem H, Knutson KL. Sleep in the modern family: protective family routines for child and adolescent sleep. Sleep Health. 2015;1(1):15–27.
25. Cappuccio FP, Taggart FM, Kandala NB, et al. Meta-analysis of short sleep duration and obesity in children and adults. Sleep. 2008;31(5):619–626.
26. Cespedes EM, Hu FB, Redline S, et al. Chronic insufficient sleep and diet quality: contributors to childhood obesity. Obesity (Silver Spring). 2016;24(1):184–190.
27. Taheri S. The link between short sleep duration and obesity: we should recommend more sleep to prevent obesity. Arch Dis Child. 2006;91(11):881–884.
28. Spiegel K, Tasali E, Leproult R, Van Cauter E. Effects of poor and short sleep on glucose metabolism and obesity risk. Nat Rev Endocrinol. 2009;5(5):253–261.
29. Androutsos O, Moschonis G, Mavrogianni C, et al. Identification of lifestyle patterns, including sleep deprivation, associated with insulin resistance in children: the Healthy Growth Study. Eur J Clin Nutr. 2014;68(3):344–349.
30. Spiegel K, Knutson K, Leproult R, Tasali E, Van Cauter E. Sleep loss: a novel risk factor for insulin resistance and type 2 diabetes. J Appl Physiol (1985). 2005;99(5):2008–2019.
31. Bass J, Turek FW. Sleepless in America: a pathway to obesity and the metabolic syndrome? Arch Intern Med. 2005;165(1):15–16.
32. Jennings JR, Muldoon MF, Hall M, Buysse DJ, Manuck SB. Selfreported sleep quality is associated with the metabolic syndrome. Sleep. 2007;30(2):219–223.
33. Hall MH, Muldoon MF, Jennings JR, Buysse DJ, Flory JD, Manuck SB. Self-reported sleep duration is associated with the metabolic syndrome in midlife adults. Sleep. 2008;31(5):635–643.
34. Gangwisch JE, Heymsfield SB, Boden-Albala B, et al. Sleep duration as a risk factor for diabetes incidence in a large U.S. sample. Sleep. 2007;30(12):1667–1673.
35. Knutson KL, Ryden AM, Mander BA, Van Cauter E. Role of sleep duration and quality in the risk and severity of type 2 diabetes mellitus. Arch Intern Med. 2006;166(16):1768–1774.
36. Shan Z, Ma H, Xie M, et al. Sleep duration and risk of type 2 diabetes: a meta-analysis of prospective studies. Diabetes Care. 2015;38(3):529–537.
37. Eguchi K, Pickering TG, Schwartz JE, et al. Short sleep duration as an independent predictor of cardiovascular events in Japanese patients with hypertension. Arch Intern Med. 2008;168(20):2225–2231.
38. Hoevenaar-Blom MP, Spijkerman AM, Kromhout D, van den Berg JF, Verschuren WM. Sleep duration and sleep quality in relation to 12-year cardiovascular disease incidence: the MORGEN study. Sleep. 2011;34(11):1487–1492.
39. Cappuccio FP, Cooper D, D’Elia L, Strazzullo P, Miller MA. Sleep duration predicts cardiovascular outcomes: a systematic review and metaanalysis of prospective studies. Eur Heart J. 2011;32(12):1484–1492.
40. Hammond EC. Some preliminary findings on physical complaints from a prospective study of 1,064,004 men and women. Am J Public Health Nations Health. 1964;54:11–23.
41. Wingard DL, Berkman LF. Mortality risk associated with sleeping patterns among adults. Sleep. 1983;6(2):102–107.
42. Cappuccio FP, D’Elia L, Strazzullo P, Miller MA. Sleep duration and all-cause mortality: a systematic review and meta-analysis of prospective studies. Sleep. 2010;33(5):585–592.
43. Liu TZ, Xu C, Rota M, et al. Sleep duration and risk of all-cause mortality: a flexible, non-linear, meta-regression of 40 prospective cohort studies. Sleep Med Rev. Epub 2016 Mar 3.
44. Patel SR, Blackwell T, Redline S, et al; Osteoporotic Fractures in Men Research Group; Study of Osteoporotic Fractures Research Group. The association between sleep duration and obesity in older adults. Int J Obes (Lond). 2008;32(12):1825–1834.
45. Buxton OM, Marcelli E. Short and long sleep are positively associated with obesity, diabetes, hypertension, and cardiovascular disease among adults in the United States. Soc Sci Med. 2010;71(5):1027–1036.
46. Chaput JP, Bouchard C, Tremblay A. Change in sleep duration and visceral fat accumulation over 6 years in adults. Obesity (Silver Spring). 2014;22(5):E9–E12.
47. Vgontzas AN, Fernandez-Mendoza J, Miksiewicz T, et al. Unveiling the longitudinal association between short sleep duration and the incidence of obesity: the Penn State Cohort. Int J Obes (Lond). 2014;38(6):825–832.
48. Taheri S, Lin L, Austin D, Young T, Mignot E. Short sleep duration is associated with reduced leptin, elevated ghrelin, and increased body mass index. PLoS Med. 2004;1(3):e62.
49. Ford ES, Li C, Wheaton AG, Chapman DP, Perry GS, Croft JB. Sleep duration and body mass index and waist circumference among U.S. adults. Obesity (Silver Spring). 2014;22(2):598–607.
50. Grodstein F, Stampfer M. The epidemiology of coronary heart disease and estrogen replacement in postmenopausal women. Prog Cardiovasc Dis. 1995;38(3):199–210.
51. Anujuo K, Stronks K, Snijder MB, et al. Relationship between short sleep duration and cardiovascular risk factors in a multi-ethnic cohort – the helius study. Sleep Med. 2015;16(12):1482–1488.
52. Donat M, Brown C, Williams N, et al. Linking sleep duration and obesity among black and white US adults. Clin Pract (Lond). 2013;10(5):661–667.
53. Gottlieb DJ, Redline S, Nieto FJ, et al. Association of usual sleep duration with hypertension: the Sleep Heart Health Study. Sleep. 2006;29(8):1009–1014.
54. Gangwisch JE, Heymsfield SB, Boden-Albala B, et al. Short sleep duration as a risk factor for hypertension: analyses of the first national health and nutrition examination survey. Hypertension. 2006;47(5):833–839.
55. Kim J, Jo I. Age-dependent association between sleep duration and hypertension in the adult Korean population. Am J Hypertens. 2010;23(12):1286–1291.
56. van den Berg JF, Tulen JH, Neven AK, et al. Sleep duration and hypertension are not associated in the elderly. Hypertension. 2007;50(3):585–589.
57. Lopez-Garcia E, Faubel R, Guallar-Castillon P, Leon-Munoz L, Banegas JR, Rodriguez-Artalejo F. Self-reported sleep duration and hypertension in older Spanish adults. J Am Geriatr Soc. 2009;57(4): 663–668.
58. Wang Q, Xi B, Liu M, Zhang Y, Fu M. Short sleep duration is associated with hypertension risk among adults: a systematic review and meta-analysis. Hypertens Res. 2012;35(10):1012–1018.
59. Stranges S, Dorn JM, Cappuccio FP, et al. A population-based study of reduced sleep duration and hypertension: the strongest association may be in premenopausal women. J Hypertens. 2010;28(5): 896–902.
60. Cappuccio FP, Stranges S, Kandala N-B, et al. Gender-specific associations of short sleep duration with prevalent and incident hypertension: the Whitehall II Study. Hypertension. 2007;50(4):693–700.
61. Fang J, Wheaton AG, Keenan NL, Greenlund KJ, Perry GS, Croft JB. Association of sleep duration and hypertension among US adults varies by age and sex. Am J Hypertens. 2012;25(3):335–341.
62. Yaggi HK, Araujo AB, McKinlay JB. Sleep duration as a risk factor for the development of type 2 diabetes. Diabetes Care. 2006;29(3): 657–661.
63. Ayas NT, White DP, Al-Delaimy WK, et al. A prospective study of self-reported sleep duration and incident diabetes in women. Diabetes Care. 2003;26(2):380–384.
64. Chaput JP, Despres JP, Bouchard C, Tremblay A. Association of sleep duration with type 2 diabetes and impaired glucose tolerance. Diabetologia. 2007;50(11):2298–2304.
65. Pyykkonen AJ, Isomaa B, Pesonen AK, et al. Sleep duration and insulin resistance in individuals without type 2 diabetes: the PPP-Botnia study. Ann Med. 2014;46(5):324–329.
66. Chang JK, Koo M, Kao VY, Chiang JK. Association of sleep duration and insulin resistance in Taiwanese vegetarians. BMC Public Health. 2012;12:666.
67. Beihl DA, Liese AD, Haffner SM. Sleep duration as a risk factor for incident type 2 diabetes in a multiethnic cohort. Ann Epidemiol. 2009;19(5):351–357.
68. Jackson CL, Redline S, Kawachi I, Hu FB. Association between sleep duration and diabetes in black and white adults. Diabetes Care. 2013;36(11):3557–3565.
69. Choi KM, Lee JS, Park HS, Baik SH, Choi DS, Kim SM. Relationship between sleep duration and the metabolic syndrome: Korean National Health and Nutrition Survey 2001. Int J Obes (Lond). 2008;32(7):1091–1097.
70. Najafian J, Toghianifar N, Mohammadifard N, Nouri F. Association between sleep duration and metabolic syndrome in a population-based study: Isfahan Healthy Heart Program. J Res Med Sci. 2011;16(6):801–806.
71. Iftikhar IH, Donley MA, Mindel J, Pleister A, Soriano S, Magalang UJ. Sleep duration and metabolic syndrome. An updated dose-risk metaanalysis. Ann Am Thorac Soc. 2015;12(9):1364–1372.
72. Ju SY, Choi WS. Sleep duration and metabolic syndrome in adult populations: a meta-analysis of observational studies. Nutr Diabetes. 2013;3:e65.
73. Wu J, Xu G, Shen L, et al. Daily sleep duration and risk of metabolic syndrome among middle-aged and older Chinese adults: cross-sectional evidence from the Dongfeng-Tongji cohort study. BMC Public Health. 2015;15:178.
74. Xi B, He D, Zhang M, Xue J, Zhou D. Short sleep duration predicts risk of metabolic syndrome: a systematic review and meta-analysis. Sleep Med Rev. 2014;18(4):293–297.
75. Wu MC, Yang YC, Wu JS, Wang RH, Lu FH, Chang CJ. Short sleep duration associated with a higher prevalence of metabolic syndrome in an apparently healthy population. Prev Med. 2012;55(4):305–309.
76. Arora T, Jiang CQ, Thomas GN, et al. Self-reported long total sleep duration is associated with metabolic syndrome: the Guangzhou Biobank Cohort Study. Diabetes Care. 2011;34(10):2317–2319.
77. Kim JY, Yadav D, Ahn SV, et al. A prospective study of total sleep duration and incident metabolic syndrome: the ARIRANG study. Sleep Med. 2015;16(12):1511–1515.
78. Chandola T, Ferrie JE, Perski A, Akbaraly T, Marmot MG. The effect of short sleep duration on coronary heart disease risk is greatest among those with sleep disturbance: a prospective study from the Whitehall II cohort. Sleep. 2010;33(6):739–744.
79. Ayas NT, White DP, Manson JE, et al. A prospective study of sleep duration and coronary heart disease in women. Arch Intern Med. 2003;163(2):205–209.
80. Sabanayagam C, Shankar A. Sleep duration and cardiovascular disease: results from the national health interview survey. Sleep. 2010;33(8):1037–1042.
81. Ford ES. Habitual sleep duration and predicted 10-year cardiovascular risk using the pooled cohort risk equations among US adults. J Am Heart Assoc. 2014;3(6):e001454.
82. Hoevenaar-Blom MP, Spijkerman AM, Kromhout D, Verschuren WM. Sufficient sleep duration contributes to lower cardiovascular disease risk in addition to four traditional lifestyle factors: the MORGEN study. Eur J Prev Cardiol. 2014;21(11):1367–1375.
83. Meisinger C, Heier M, Lowel H, Schneider A, Doring A. Sleep duration and sleep complaints and risk of myocardial infarction in middle-aged men and women from the general population: the MONICA/KORA Augsburg cohort study. Sleep. 2007;30(9):1121–1127.
84. Strand LB, Tsai MK, Gunnell D, Janszky I, Wen CP, Chang SS. Self-reported sleep duration and coronary heart disease mortality: a large cohort study of 400,000 Taiwanese adults. Int J Cardiol. 2016;207:246–251.
85. Hirshkowitz M, Whiton K, Albert SM, et al. National sleep foundation’s sleep time duration recommendations: methodology and results summary. Sleep Health. 2015;1(1):40–43.
86. Sleep in America Poll. Sleep in the modern family. Sleep Health. 2014;1(2):e13.
87. Sleep in America Poll. Teens and sleep. Sleep Health. 2006;1(2):e5.
88. Eaton DK, Kann L, Kinchen S, et al. Youth risk behavior surveillance – United States, 2009. MMWR Morb Mortal Wkly Rep. 2010; 59(5):1–142.
89. Matthews KA, Hall M, Dahl RE. Sleep in healthy black and white adolescents. Pediatrics. 2014;133(5):e1189–e1196.
90. Rudnicka AR, Nightingale CM, Donin AS, et al. Sleep duration and risk markers for type 2 diabetes: a cross-sectional study in children aged 9–10 years. Lancet. 2015;386:S4.
91. He F, Bixler EO, Fernandez-Mendoza J, et al. Abstract P312: lack of association between habitual sleep duration and obesity measures in adolescents with adequate sleep. Circulation. 2016;133(suppl 1):A312.
92. Taveras EM, Rifas-Shiman SL, Oken E, Gunderson EP, Gillman MW. Short sleep duration in infancy and risk of childhood overweight. Arch Pediatr Adolesc Med. 2008;162(4):305–311.
93. von Kries R, Toschke AM, Wurmser H, Sauerwald T, Koletzko B. Reduced risk for overweight and obesity in 5- and 6-y-old children by duration of sleep – a cross-sectional study. Int J Obes Relat Metab Disord. 2002;26(5):710–716.
94. Touchette E, Petit D, Tremblay RE, et al. Associations between sleep duration patterns and overweight/obesity at age 6. Sleep. 2008;31(11):1507–1514.
95. Taveras EM, Gillman MW, Pena MM, Redline S, Rifas-Shiman SL. Chronic sleep curtailment and adiposity. Pediatrics. 2014;133(6):1013–1022.
96. Chaput JP, Brunet M, Tremblay A. Relationship between short sleeping hours and childhood overweight/obesity: results from the ‘Quebec en Forme’ Project. Int J Obes. 2006;30(7):1080–1085.
97. Sluggett L, Wagner SL, Hardy C, Harris RL. Associations between sleep duration and indicators of cardiometabolic disease in Canadian children and adolescents: analyses of the 2007-2009 Canadian health measures survey. Child Obes. Epub 2016 May 19.
98. Kong AP, Wing YK, Choi KC, et al. Associations of sleep duration with obesity and serum lipid profile in children and adolescents. Sleep Med. 2011;12(7):659–665.
99. Garaulet M, Ortega FB, Ruiz JR, et al. Short sleep duration is associated with increased obesity markers in European adolescents: effect of physical activity and dietary habits. The HELENA study. Int J Obes (Lond). 2011;35(10):1308–1317.
100. Mitchell JA, Rodriguez D, Schmitz KH, Audrain-McGovern J. Sleep duration and adolescent obesity. Pediatrics. 2013;131(5):e1428–e1434.
101. Spruyt K, Molfese DL, Gozal D. Sleep duration, sleep regularity, body weight, and metabolic homeostasis in school-aged children. Pediatrics. 2011;127(2):e345–e352.
102. He F, Bixler EO, Berg A, et al. Habitual sleep variability, not sleep duration, is associated with caloric intake in adolescents. Sleep Med. 2015;16(7):856–861.
103. Landhuis CE, Poulton R, Welch D, Hancox RJ. Childhood sleep time and long-term risk for obesity: a 32-year prospective birth cohort study. Pediatrics. 2008;122(5):955–960.
104. Eisenmann JC, Ekkekakis P, Holmes M. Sleep duration and overweight among Australian children and adolescents. Acta Paediatr. 2006;95(8):956–963.
105. Hitze B, Bosy-Westphal A, Bielfeldt F, et al. Determinants and impact of sleep duration in children and adolescents: data of the Kiel Obesity Prevention Study. Eur J Clin Nutr. 2009;63(6):739–746.
106. Pedrosa R, Sena A, Cardoso A, et al. Sleep duration and cardiovascular risk in children and adolescents with overweight/obesity. Eur Respir J. 2013;42(suppl):57.
107. Valrie CR, Bond K, Lutes LD, Carraway M, Collier DN. Relationship of sleep quality, baseline weight status, and weight-loss responsiveness in obese adolescents in an immersion treatment program. Sleep Med. 2015;16(3):432–434.
108. Navarro-Solera M, Carrasco-Luna J, Pin-Arboledas G, GonzalezCarrascosa R, Soriano JM, Codoner-Franch P. Short sleep duration is related to emerging cardiovascular risk factors in obese children. J Pediatr Gastroenterol Nutr. 2015;61(5):571–576.
109. Schäfer AA, Domingues MR, Dahly DL, et al. Sleep duration trajectories and body composition in adolescents: prospective birth cohort study. PLoS One. 2016;11(3):e0152348.
110. Sampei M, Dakeishi M, Wood DC, Murata K. Impact of total sleep duration on blood pressure in preschool children. Biomed Res. 2006;27(3):111–115.
111. Au CT, Ho CKW, Wing YK, Lam HS, Li AM. Acute and chronic effects of sleep duration on blood pressure. Pediatrics. 2014;133(1):e64–e72.
112. Javaheri S, Storfer-Isser A, Rosen CL, Redline S. Sleep quality and elevated blood pressure in adolescents. Circulation. 2008;118(10):1034–1040.
113. Hannon TS, Tu W, Watson SE, Jalou H, Chakravorty S, Arslanian SA. Morning blood pressure is associated with sleep quality in obese adolescents. J Pediatr. 2014;164(2):313–317.
114. Mezick EJ, Hall M, Matthews KA. Sleep duration and ambulatory blood pressure in black and white adolescents. Hypertension. 2012;59(3):747–752.
115. Rodriguez-Colon SM, He F, Bixler EO, et al. Sleep variability and cardiac autonomic modulation in adolescents – Penn State Child Cohort (PSCC) study. Sleep Med. 2015;16(1):67–72.
116. Bayer O, Neuhauser H, von Kries R. Sleep duration and blood pressure in children: a cross-sectional study. J Hypertens. 2009;27(9):1789–1793.
117. Martikainen S, Pesonen AK, Feldt K, et al. Poor sleep and cardiovascular function in children. Hypertension. 2011;58(1):16–21.
118. Flint J, Kothare SV, Zihlif M, et al. Association between inadequate sleep and insulin resistance in obese children. J Pediatr. 2007;150(4):364–369.
119. Sayin FK, Buyukinan M. Sleep duration and media time have a major impact on insulin resistance and metabolic risk factors in obese children and adolescents. Child Obes. Epub 2016 Mar 15.
120. Matthews KA, Dahl RE, Owens JF, Lee L, Hall M. Sleep duration and insulin resistance in healthy black and white adolescents. Sleep. 2012;35(10):1353–1358.
121. Dorenbos E, Rijks JM, Adam TC, Westerterp-Plantenga MS, Vreugdenhil AC. Sleep efficiency as a determinant of insulin sensitivity in overweight and obese adolescents. Diabetes Obes Metab. 2015;17(suppl 1): 90–98.
122. De Bernardi Rodrigues AM, da Silva Cde C, Vasques AC, et al; Brazilian Metabolic Syndrome Study (BRAMS) Investigators. Association of sleep deprivation with reduction in insulin sensitivity as assessed by the hyperglycemic clamp technique in adolescents. JAMA Pediatr. 2016;170(5):487–494.
123. Tian Z, Ye T, Zhang X, et al. Sleep duration and hyperglycemia among obese and nonobese children aged 3 to 6 years. Arch Pediatr Adolesc Med. 2010;164(1):46–52.
124. Zhu Y, Li AM, Au CT, et al. Association between sleep architecture and glucose tolerance in children and adolescents. J Diabetes. 2015;7(1):10–15.
125. Koren D, Levitt Katz LE, Brar PC, Gallagher PR, Berkowitz RI, Brooks LJ. Sleep architecture and glucose and insulin homeostasis in obese adolescents. Diabetes Care. 2011;34(11):2442–2447.
126. Koren D, Gozal D, Philby MF, Bhattacharjee R, Kheirandish-Gozal L. Impact of obstructive sleep apnoea on insulin resistance in nonobese and obese children. Eur Respir J. 2016;47(4):1152–1161.
127. Dabelea D, Mayer-Davis EJ, Saydah S, et al; SEARCH for Diabetes in Youth Study. Prevalence of type 1 and type 2 diabetes among children and adolescents from 2001 to 2009. JAMA. 2014;311(17):1778–1786.
128. Gangwisch JE, Malaspina D, Babiss LA, et al. Short sleep duration as a risk factor for hypercholesterolemia: analyses of the National Longitudinal Study of Adolescent Health. Sleep. 2010;33(7):956–961.
129. Lee JA, Park HS. Relation between sleep duration, overweight, and metabolic syndrome in Korean adolescents. Nutr Metab Cardiovasc Dis. 2014;24(1):65–71.
130. Azadbakht L, Kelishadi R, Khodarahmi M, et al. The association of sleep duration and cardiometabolic risk factors in a national sample of children and adolescents: the CASPIAN III study. Nutrition. 2013;29(9):1133–1141.
131. Berentzen NE, Smit HA, Bekkers MBM, et al. Time in bed, sleep quality and associations with cardiometabolic markers in children: the prevention and incidence of asthma and mite allergy birth cohort study. J Sleep Res. 2014;23(1):3–12.
132. Narang I, Manlhiot C, Davies-Shaw J, et al. Sleep disturbance and cardiovascular risk in adolescents. CMAJ. 2012;184(17):E913–E920.
133. Rey-Lopez JP, de Carvalho HB, de Moraes AC, et al; HELENA study. Sleep time and cardiovascular risk factors in adolescents: the HELENA (Healthy Lifestyle in Europe by Nutrition in Adolescence) study. Sleep Med. 2014;15(1):104–110.
134. Hjorth MF, Chaput JP, Damsgaard CT, et al. Low physical activity level and short sleep duration are associated with an increased cardiometabolic risk profile: a longitudinal study in 8-11 year old Danish children. PLoS One. 2014;9(8):e104677.
135. Fadzlina A, Harun F, Nurul Haniza M, et al. Metabolic syndrome among 13 year old adolescents: prevalence and risk factors. BMC Public Health. 2014;14(3):1–8.
136. Sung V, Beebee DW, Vandyke R, et al. Does sleep duration predict metabolic risk in obese adolescents attending tertiary services? A cross-sectional study. Sleep. 2011;34(7):891–898.
137. Spaeth AM, Dinges DF, Goel N. Effects of experimental sleep restriction on weight gain, caloric intake, and meal timing in healthy adults. Sleep. 2013;36(7):981–990.
138. Jung CM, Melanson EL, Frydendall EJ, Perreault L, Eckel RH, Wright KP. Energy expenditure during sleep, sleep deprivation and sleep following sleep deprivation in adult humans. J Physiol. 2011;589(pt 1):235–244.
139. Markwald RR, Melanson EL, Smith MR, et al. Impact of insufficient sleep on total daily energy expenditure, food intake, and weight gain. Proc Natl Acad Sci USA. 2013;110(14):5695–5700.
140. St-Onge MP, Roberts AL, Chen J, et al. Short sleep duration increases energy intakes but does not change energy expenditure in normalweight individuals. Am J Clin Nutr. 2011;94(2):410–416.
141. Nedeltcheva AV, Kilkus JM, Imperial J, Kasza K, Schoeller DA, Penev PD. Sleep curtailment is accompanied by increased intake of calories from snacks. Am J Clin Nutr. 2009;89(1):126–133.
142. Spaeth AM, Dinges DF, Goel N. Sex and race differences in caloric intake during sleep restriction in healthy adults. Am J Clin Nutr. 2014;100(2):559–566.
143. Brondel L, Romer MA, Nougues PM, Touyarou P, Davenne D. Acute partial sleep deprivation increases food intake in healthy men. Am J Clin Nutr. 2010;91(6):1550–1559.
144. Calvin AD, Carter RE, Adachi T, et al. Effects of experimental sleep restriction on caloric intake and activity energy expenditure. Chest. 2013;144(1):79–86.
145. Bromley LE, Booth JN 3rd, Kilkus JM, Imperial JG, Penev PD. Sleep restriction decreases the physical activity of adults at risk for type 2 diabetes. Sleep. 2012;35(7):977–984.
146. Tasali E, Chapotot F, Wroblewski K, Schoeller D. The effects of extended bedtimes on sleep duration and food desire in overweight young adults: a home-based intervention. Appetite. 2014;80:220–224.
147. Schmid SM, Hallschmid M, Jauch-Chara K, Born J, Schultes B. A single night of sleep deprivation increases ghrelin levels and feelings of hunger in normal-weight healthy men. J Sleep Res. 2008;17(3):331–334.
148. Spiegel K, Tasali E, Penev P, Van Cauter E. Brief communication: sleep curtailment in healthy young men is associated with decreased leptin levels, elevated ghrelin levels, and increased hunger and appetite. Ann Intern Med. 2004;141(11):846–850.
149. Omisade A, Buxton OM, Rusak B. Impact of acute sleep restriction on cortisol and leptin levels in young women. Physiol Behav. 2010;99(5):651–656.
150. St-Onge MP, O’Keeffe M, Roberts AL, RoyChoudhury A, Laferrere B. Short sleep duration, glucose dysregulation and hormonal regulation of appetite in men and women. Sleep. 2012;35(11):1503–1510.
151. Broussard JL, Kilkus JM, Delebecque F, et al. Elevated ghrelin predicts food intake during experimental sleep restriction. Obesity (Silver Spring). 2016;24(1):132–138.
152. Spiegel K, Leproult R, L’Hermite-Baleriaux M, Copinschi G, Penev PD, Van Cauter E. Leptin levels are dependent on sleep duration: relationships with sympathovagal balance, carbohydrate regulation, cortisol, and thyrotropin. J Clin Endocrinol Metab. 2004;89(11): 5762–5771.
153. Spiegel K, Leproult R, Van Cauter E. Impact of sleep debt on metabolic and endocrine function. Lancet. 1999;354(9188):1435–1439.
154. Magee CA, Huang X-F, Iverson DC, Caputi P. Acute sleep restriction alters neuroendocrine hormones and appetite in healthy male adults. Sleep Biol Rhythms. 2009;7(2):125–127.
155. Killick R, Hoyos CM, Melehan KL, Dungan GC 2 nd, Poh J, Liu PY. Metabolic and hormonal effects of ‘catch-up’ sleep in men with chronic, repetitive, lifestyle-driven sleep restriction. Clin Endocrinol (Oxf). 2015;83(4):498–507.
156. Buxton OM, Pavlova M, Reid EW, Wang W, Simonson DC, Adler GK. Sleep restriction for 1 week reduces insulin sensitivity in healthy men. Diabetes. 2010;59(9):2126–2133.
157. Nedeltcheva AV, Kessler L, Imperial J, Penev PD. Exposure to recurrent sleep restriction in the setting of high caloric intake and physical inactivity results in increased insulin resistance and reduced glucose tolerance. J Clin Endocrinol Metab. 2009;94(9):3242–3250.
158. Donga E, van Dijk M, van Dijk JG, et al. A single night of partial sleep deprivation induces insulin resistance in multiple metabolic pathways in healthy subjects. J Clin Endocrinol Metab. 2010;95(6):2963–2968.
159. Faraut B, Nakib S, Drogou C, et al. Napping reverses the salivary interleukin-6 and urinary norepinephrine changes induced by sleep restriction. J Clin Endocrinol Metab. 2015;100(3):E416–E426.
160. van Leeuwen WM, Lehto M, Karisola P, et al. Sleep restriction increases the risk of developing cardiovascular diseases by augmenting proinflammatory responses through IL-17 and CRP. PLoS One. 2009;4(2):e4589.
161. Ferrie JE, Kivimaki M, Akbaraly TN, et al. Associations between change in sleep duration and inflammation: findings on C-reactive protein and interleukin 6 in the Whitehall II Study. Am J Epidemiol. 2013;178(6):956–961.
162. Broussard JL, Ehrmann DA, Van Cauter E, Tasali E, Brady MJ. Impaired insulin signaling in human adipocytes after experimental sleep restriction: a randomized, crossover study. Ann Intern Med. 2012;157(8):549–557.
163. Cedernaes J, Osler ME, Voisin S, et al. Acute sleep loss induces tissuespecific epigenetic and transcriptional alterations to circadian clock genes in men. J Clin Endocrinol Metab. 2015;100(9):E1255–E1261.
164. Moller-Levet CS, Archer SN, Bucca G, et al. Effects of insufficient sleep on circadian rhythmicity and expression amplitude of the human blood transcriptome. Proc Natl Acad Sci U S A. 2013;110(12): E1132–E1141.
165. Leproult R, Deliens G, Gilson M, Peigneux P. Beneficial impact of sleep extension on fasting insulin sensitivity in adults with habitual sleep restriction. Sleep. 2015;38(5):707–715.
166. Arnal PJ, Drogou C, Sauvet F, et al. Effect of sleep extension on the subsequent testosterone, cortisol and prolactin responses to total sleep deprivation and recovery. J Neuroendocrinol. 2016;28(2):12346.
167. Ogawa Y, Kanbayashi T, Saito Y, et al. Total sleep deprivation elevates blood pressure through arterial baroreflex resetting: a study with microneurographic technique. Sleep. 2003;26(8):986–989.
168. Zhong X, Hilton HJ, Gates GJ, et al. Increased sympathetic and decreased parasympathetic cardiovascular modulation in normal humans with acute sleep deprivation. J Appl Physiol (1985). 2005;98(6):2024–2032.
169. Lusardi P, Zoppi A, Preti P, Pesce RM, Piazza E, Fogari R. Effects of insufficient sleep on blood pressure in hypertensive patients: a 24-h study. Am J Hypertens. 1999;12(1 pt 1):63–68.
170. Covassin N, Bukartyk J, Sahakyan K, et al. Experimental sleep restriction increases nocturnal blood pressure and attenuates blood pressure dipping in healthy individuals. J Am Coll Cardiol. 2015;65(10_S):61352–61353.
171. Sauvet F, Leftheriotis G, Gomez-Merino D, et al. Effect of acute sleep deprivation on vascular function in healthy subjects. J Appl Physiol (1985). 2010;108(1):68–75.
172. Calvin AD, Covassin N, Kremers WK, et al. Experimental sleep restriction causes endothelial dysfunction in healthy humans. J Am Heart Assoc. 2014;3(6):e001143.
173. Yang H, Durocher JJ, Larson RA, Dellavalla JP, Carter JR. Total sleep deprivation alters cardiovascular reactivity to acute stressors in humans. J Appl Physiol (1985). 2012;113(6):903–908.
174. Holmes AL, Burgess HJ, Dawson D. Effects of sleep pressure on endogenous cardiac autonomic activity and body temperature. J Appl Physiol (1985). 2002;92(6):2578–2584.
175. Sunbul M, Kanar BG, Durmus E, Kivrak T, Sari I. Acute sleep deprivation is associated with increased arterial stiffness in healthy young adults. Sleep Breath. 2014;18(1):215–220.
176. Cakici M, Dogan A, Cetin M, et al. Negative effects of acute sleep deprivation on left ventricular functions and cardiac repolarization in healthy young adults. Pacing Clin Electrophysiol. 2015;38(6):713–722.
177. O’Keeffe M, Roberts AL, Kelleman M, Roychoudhury A, St-Onge MP. No effects of short-term sleep restriction, in a controlled feeding setting, on lipid profiles in normal-weight adults. J Sleep Res. 2013;22(6):717–720.
178. Reynolds AC, Dorrian J, Liu PY, et al. Impact of five nights of sleep restriction on glucose metabolism, leptin and testosterone in young adult men. PLoS One. 2012;7(7):e41218.
179. Kerkhofs M, Boudjeltia KZ, Stenuit P, Brohee D, Cauchie P, Vanhaeverbeek M. Sleep restriction increases blood neutrophils, total cholesterol and low density lipoprotein cholesterol in postmenopausal women: a preliminary study. Maturitas. 2007;56(2):212–215.
180. Boudjeltia KZ, Faraut B, Esposito MJ, et al. Temporal dissociation between myeloperoxidase (MPO)-modified LDL and MPO elevations during chronic sleep restriction and recovery in healthy young men. PLoS One. 2011;6(11):e28230.
181. Delporte C, Van Antwerpen P, Vanhamme L, Roumeguere T, Zouaoui Boudjeltia K. Low-density lipoprotein modified by myeloperoxidase in inflammatory pathways and clinical studies. Mediators Inflamm. 2013;2013:971579.
182. Aho V, Ollila HM, Kronholm E, et al. Prolonged sleep restriction induces changes in pathways involved in cholesterol metabolism and inflammatory responses. Sci Rep. 2016;6:24828.
183. Poirier A, Gendron M, Vriend J, Davidson F, Corkum P. The impact of sleep restriction on daytime movement in typically developing children. Atten Defic Hyperact Disord. 2016;8(1):53–58.
184. Hart CN, Carskadon MA, Considine RV, et al. Changes in children’s sleep duration on food intake, weight, and leptin. Pediatrics. 2013;132(6):e1473–e1480.
185. Weiss A, Xu F, Storfer-Isser A, Thomas A, Ievers-Landis CE, Redline S. The association of sleep duration with adolescents’ fat and carbohydrate consumption. Sleep. 2010;33(9):1201–1209.
186. Beebe DW, Simon S, Summer S, Hemmer S, Strotman D, Dolan LM. Dietary intake following experimentally restricted sleep in adolescents. Sleep. 2013;36(6):827–834.
187. Simon SL, Field J, Miller LE, DiFrancesco M, Beebe DW. Sweet/ dessert foods are more appealing to adolescents after sleep restriction. PLoS One. 2015;10(2):e0115434.
188. O’Sullivan KL, Dumin M, Kheirandish-Gozal L, Bhattacharjee R, Gozal D, Koren D. The effects of acute sleep restriction on weight and cardiometabolic risk indices in obese adolescents. In: Cardiometabolic Risk/Vascular Biology (posters): FRI-676; 2016; Boston.
189. Klingenberg L, Chaput JP, Holmback U, et al. Acute sleep restriction reduces insulin sensitivity in adolescent boys. Sleep. 2013;36(7):1085–1090.
190. Young T, Skatrud J, Peppard PE. Risk factors for obstructive sleep apnea in adults. JAMA. 2004;291(16):2013–2016.
191. Verhulst SL, Schrauwen N, Haentjens D, et al. Sleep-disordered breathing in overweight and obese children and adolescents: prevalence, characteristics and the role of fat distribution. Arch Dis Child. 2007;92(3):205–208.
192. Yuan H, Schwab RJ, Kim C, et al. Relationship between body fat distribution and upper airway dynamic function during sleep in adolescents. Sleep. 2013;36(8):1199–1207.
193. Arens R, Muzumdar H. Childhood obesity and obstructive sleep apnea syndrome. J Appl Physiol (1985). 2010;108(2):436–444.
194. Ip MS, Lam B, Ng MM, Lam WK, Tsang KW, Lam KS. Obstructive sleep apnea is independently associated with insulin resistance. Am J Respir Crit Care Med. 2002;165(5):670–676.
195. Pamidi S, Wroblewski K, Broussard J, et al. Obstructive sleep apnea in young lean men: impact on insulin sensitivity and secretion. Diabetes Care. 2012;35(11):2384–2389.
196. Punjabi NM, Shahar E, Redline S, et al; Sleep Heart Health Study. Sleep-disordered breathing, glucose intolerance, and insulin resistance: the sleep heart health study. Am J Epidemiol. 2004;160(6):521–530.
197. Parish JM, Adam T, Facchiano L. Relationship of metabolic syndrome and obstructive sleep apnea. J Clin Sleep Med. 2007;3(5):467–472.
198. Muraki I, Tanigawa T, Yamagishi K, et al; CIRCS Investigators. Nocturnal intermittent hypoxia and the development of type 2 diabetes: the circulatory risk in communities study (CIRCS). Diabetologia. 2010;53(3):481–488.
199. Tasali E, Mokhlesi B, Van Cauter E. Obstructive sleep apnea and type 2 diabetes: interacting epidemics. Chest. 2008;133(2):496–506.
200. Babu AR, Herdegen J, Fogelfeld L, Shott S, Mazzone T. Type 2 diabetes, glycemic control, and continuous positive airway pressure in obstructive sleep apnea. Arch Intern Med. 2005;165(4):447–452.
201. Grimaldi D, Beccuti G, Touma C, Van Cauter E, Mokhlesi B. Association of obstructive sleep apnea in rapid eye movement sleep with reduced glycemic control in type 2 diabetes: therapeutic implications. Diabetes Care. 2014;37(2):355–363.
202. Aronsohn RS, Whitmore H, Van Cauter E, Tasali E. Impact of untreated obstructive sleep apnea on glucose control in type 2 diabetes. Am J Respir Crit Care Med. 2010;181(5):507–513.
203. Newman AB, Nieto FJ, Guidry U, et al; Sleep Heart Health Study Research Group. Relation of sleep-disordered breathing to cardiovascular disease risk factors: the sleep heart health study. Am J Epidemiol. 2001;154(1):50–59.
204. Yaggi HK, Concato J, Kernan WN, Lichtman JH, Brass LM, Mohsenin V. Obstructive sleep apnea as a risk factor for stroke and death. N Engl J Med. 2005;353(19):2034–2041.
205. Partinen M, Jamieson A, Guilleminault C. Long-term outcome for obstructive sleep apnea syndrome patients. Mortality. Chest. 1988;94(6):1200–1204.
206. Marshall NS, Wong KK, Liu PY, Cullen SR, Knuiman MW, Grunstein RR. Sleep apnea as an independent risk factor for all-cause mortality: the Busselton Health Study. Sleep. 2008;31(8):1079–1085.
207. Epstein LJ, Kristo D, Strollo PJ Jr, et al; Adult Obstructive Sleep Apnea Task Force of the American Academy of Sleep Medicine. Clinical guideline for the evaluation, management and long-term care of obstructive sleep apnea in adults. J Clin Sleep Med. 2009;5(3):263–276.
208. Marcus CL, Brooks LJ, Draper KA, et al; American Academy of Pediatrics. Diagnosis and management of childhood obstructive sleep apnea syndrome. Pediatrics. 2012;130(3):576–584.
209. Marcus CL. Sleep-disordered breathing in children. Am J Respir Crit Care Med. 2001;164(1):16–30.
210. Fuentes-Pradera MA, Sánchez-Armengol Á, Capote-Gil F, et al. Effects of sex on sleep-disordered breathing in adolescents. Eur Respir J. 2004;23(2):250–254.
211. Dancey DR, Hanly PJ, Soong C, Lee B, Hoffstein V. Impact of menopause on the prevalence and severity of sleep apnea. Chest. 2001;120(1):151–155.
212. Ronen O, Malhotra A, Pillar G. Influence of gender and age on upper-airway length during development. Pediatrics. 2007;120(4):e1028–e1034.
213. Cistulli PA, Grunstein RR, Sullivan CE. Effect of testosterone administration on upper airway collapsibility during sleep. Am J Respir Crit Care Med. 1994;149(2 pt 1):530–532.
214. Peppard PE, Young T, Barnet JH, Palta M, Hagen EW, Hla KM. Increased prevalence of sleep-disordered breathing in adults. Am J Epidemiol. 2013;177(9):1006–1014.
215. Romero-Corral A, Caples SM, Lopez-Jimenez F, Somers VK. Interactions between obesity and obstructive sleep apnea: implications for treatment. Chest. 2010;137(3):711–719.
216. Resta O, Foschino-Barbaro MP, Legari G, et al. Sleep-related breathing disorders, loud snoring and excessive daytime sleepiness in obese subjects. Int J Obes Relat Metab Disord. 2001;25(5):669–675.
217. Schwartz AR, Patil SP, Laffan AM, Polotsky V, Schneider H, Smith PL. Obesity and obstructive sleep apnea. Proc Am Thorac Soc. 2008;5(2):185–192.
218. Fritscher LG, Mottin CC, Canani S, Chatkin JM. Obesity and obstructive sleep apnea-hypopnea syndrome: the impact of bariatric surgery. Obes Surg. 2007;17(1):95–99.
219. Redenius R, Murphy C, O’Neill E, Al-Hamwi M, Zallek SN. Does CPAP lead to change in BMI. J Clin Sleep Med. 2008;4(3): 205–209.
220. Chin K, Shimizu K, Nakamura T, et al. Changes in intra-abdominal visceral fat and serum leptin levels in patients with obstructive sleep apnea syndrome following nasal continuous positive airway pressure therapy. Circulation. 1999;100(7):706–712.
221. Quan SF, Budhiraja R, Clarke DP, et al. Impact of treatment with continuous positive airway pressure (CPAP) on weight in obstructive sleep apnea. J Clin Sleep Med. 2013;9(10):989–993.
222. Stenlof K, Grunstein R, Hedner J, Sjostrom L. Energy expenditure in obstructive sleep apnea: effects of treatment with continuous positive airway pressure. Am J Physiol. 1996;271(6):E1036–E1043.
223. Peled N, Kassirer M, Shitrit D, et al. The association of OSA with insulin resistance, inflammation and metabolic syndrome. Respir Med. 2007;101(8):1696–1701.
224. Lindberg E, Theorell-Haglow J, Svensson M, Gislason T, Berne C, Janson C. Sleep apnea and glucose metabolism: a long-term follow-up in a community-based sample. Chest. 2012;142(4):935–942.
225. Punjabi NM, Beamer BA. Alterations in glucose disposal in sleep-disordered breathing. Am J Respir Crit Care Med. 2009;179(3):235–240.
226. Elmasry A, Lindberg E, Berne C, et al. Sleep-disordered breathing and glucose metabolism in hypertensive men: a population-based study. J Intern Med. 2001;249(2):153–161.
227. Fredheim JM, Rollheim J, Omland T, et al. Type 2 diabetes and prediabetes are associated with obstructive sleep apnea in extremely obese subjects: a cross-sectional study. Cardiovasc Diabetol. 2011;10:84.
228. Reichmuth KJ, Austin D, Skatrud JB, Young T. Association of sleep apnea and type II diabetes: a population-based study. Am J Respir Crit Care Med. 2005;172(12):1590–1595.
229. Marshall NS, Wong KK, Phillips CL, Liu PY, Knuiman MW, Grunstein RR. Is sleep apnea an independent risk factor for prevalent and incident diabetes in the Busselton Health Study? J Clin Sleep Med. 2009;5(1):15–20.
230. Botros N, Concato J, Mohsenin V, Selim B, Doctor K, Yaggi HK. Obstructive sleep apnea as a risk factor for type 2 diabetes. Am J Med. 2009;122(12):1122–1127.
231. Celen YT, Hedner J, Carlson J, Peker Y. Impact of gender on incident diabetes mellitus in obstructive sleep apnea: a 16-year follow-up. J Clin Sleep Med. 2010;6(3):244–250.
232. Kendzerska T, Gershon AS, Hawker G, Tomlinson G, Leung RS. Obstructive sleep apnea and incident diabetes. A historical cohort study. Am J Respir Crit Care Med. 2014;190(2):218–225.
233. Foster GD, Sanders MH, Millman R, et al; Sleep AHEAD Research Group. Obstructive sleep apnea among obese patients with type 2 diabetes. Diabetes Care. 2009;32(6):1017–1019.
234. Shaw JE, Punjabi NM, Wilding JP, Alberti KG, Zimmet PZ, International Diabetes Federation Taskforce on Epidemiology and Prevention. Sleep-disordered breathing and type 2 diabetes: a report from the international diabetes federation taskforce on epidemiology and prevention. Diabetes Res Clin Pract. 2008;81(1):2–12.
235. Harsch IA, Schahin SP, Radespiel-Troger M, et al. Continuous positive airway pressure treatment rapidly improves insulin sensitivity in patients with obstructive sleep apnea syndrome. Am J Respir Crit Care Med. 2004;169(2):156–162.
236. Harsch IA, Schahin SP, Bruckner K, et al. The effect of continuous positive airway pressure treatment on insulin sensitivity in patients with obstructive sleep apnoea syndrome and type 2 diabetes. Respiration. 2004;71(3):252–259.
237. Chirinos JA, Gurubhagavatula I, Teff K, et al. CPAP, weight loss, or both for obstructive sleep apnea. N Engl J Med. 2014;370(24):2265–2275.
238. Garcia JM, Sharafkhaneh H, Hirshkowitz M, Elkhatib R, Sharafkhaneh A. Weight and metabolic effects of CPAP in obstructive sleep apnea patients with obesity. Respir Res. 2011;12(1):80.
239. Guest JF, Panca M, Sladkevicius E, Taheri S, Stradling J. Clinical outcomes and cost-effectiveness of continuous positive airway pressure to manage obstructive sleep apnea in patients with type 2 diabetes in the U.K. Diabetes Care. 2014;37(5):1263–1271.
240. West SD, Nicoll DJ, Wallace TM, Matthews DR, Stradling JR. Effect of CPAP on insulin resistance and HbA1c in men with obstructive sleep apnoea and type 2 diabetes. Thorax. 2007;62(11): 969–974.
241. Martínez-Cerón E, Barquiel B, Bezos A-M, et al. Effect of CPAP on glycemic control in patients with obstructive sleep apnea and type 2 diabetes. A randomized clinical trial. Am J Respir Crit Care Med. Epub 2016 Feb 24.
242. Kapa S, Sert Kuniyoshi FH, Somers VK. Sleep apnea and hypertension: interactions and implications for management. Hypertension. 2008;51(3):605–608.
243. Nieto FJ, Young TB, Lind BK, et al. Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. Sleep heart health study. JAMA. 2000;283(14):1829–1836.
244. Peppard PE, Young T, Palta M, Skatrud J. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med. 2000;342(19):1378–1384.
245. Peker Y, Hedner J, Norum J, Kraiczi H, Carlson J. Increased incidence of cardiovascular disease in middle-aged men with obstructive sleep apnea: a 7-year follow-up. Am J Respir Crit Care Med. 2002;166(2):159–165.
246. Hla KM, Young TB, Bidwell T, Palta M, Skatrud JB, Dempsey J. Sleep apnea and hypertension. A population-based study. Ann Intern Med. 1994;120(5):382–388.
247. Drager LF, Pereira AC, Barreto-Filho JA, et al. Phenotypic characteristics associated with hypertension in patients with obstructive sleep apnea. J Hum Hypertens. 2006;20(7):523–528.
248. Suzuki M, Guilleminault C, Otsuka K, Shiomi T. Blood pressure “dipping” and “non-dipping” in obstructive sleep apnea syndrome patients. Sleep. 1996;19(5):382–387.
249. Ashram YA, Abdel Wahab NH, Diab IH. Non-dipping pattern of nocturnal blood pressure in obstructive sleep apnea syndrome: possible role of oxidative stress and endothelin-1 precursor. Alexandria J Med. 2013;49(2):153–161.
250. Loredo JS, Ancoli-Israel S, Dimsdale JE. Sleep quality and blood pressure dipping in obstructive sleep apnea. Am J Hypertens. 2001;14(9):887–892.
251. Logan AG, Perlikowski SM, Mente A, et al. High prevalence of unrecognized sleep apnoea in drug-resistant hypertension. J Hypertens. 2001;19(12):2271–2277.
252. Pedrosa RP, Drager LF, Gonzaga CC, et al. Obstructive sleep apnea: the most common secondary cause of hypertension associated with resistant hypertension. Hypertension. 2011;58(5):811–817.
253. Haentjens P, Van Meerhaeghe A, Moscariello A, et al. The impact of continuous positive airway pressure on blood pressure in patients with obstructive sleep apnea syndrome: evidence from a metaanalysis of placebo-controlled randomized trials. Arch Intern Med. 2007;167(8):757–764.
254. Alajmi M, Mulgrew AT, Fox J, et al. Impact of continuous positive airway pressure therapy on blood pressure in patients with obstructive sleep apnea hypopnea: a meta-analysis of randomized controlled trials. Lung. 2007;185(2):67–72.
255. Bazzano LA, Khan Z, Reynolds K, He J. Effect of nocturnal nasal continuous positive airway pressure on blood pressure in obstructive sleep apnea. Hypertension. 2007;50(2):417–423.
256. Martinez-Garcia MA, Capote F, Campos-Rodriguez F, et al; Spanish Sleep Network. Effect of CPAP on blood pressure in patients with obstructive sleep apnea and resistant hypertension: the HIPARCO randomized clinical trial. JAMA. 2013;310(22):2407–2415.
257. Bratton DJ, Gaisl T, Wons AM, Kohler M. CPAP vs mandibular advancement devices and blood pressure in patients with obstructive sleep apnea: a systematic review and meta-analysis. JAMA. 2015;314(21):2280–2293.
258. McArdle N, Hillman D, Beilin L, Watts G. Metabolic risk factors for vascular disease in obstructive sleep apnea: a matched controlled study. Am J Respir Crit Care Med. 2007;175(2):190–195.
259. Qian Y, Yi H, Zou J, et al. Independent association between sleep fragmentation and dyslipidemia in patients with obstructive sleep apnea. Sci Rep. 2016;6:26089.
260. Wu WT, Tsai SS, Shih TS, et al. The association between obstructive sleep apnea and metabolic markers and lipid profiles. PLoS One. 2015;10(6):e0130279.
261. Coughlin SR, Mawdsley L, Mugarza JA, Calverley PM, Wilding JP. Obstructive sleep apnoea is independently associated with an increased prevalence of metabolic syndrome. Eur Heart J. 2004;25(9):735–741.
262. Nadeem R, Singh M, Nida M, et al. Effect of obstructive sleep apnea hypopnea syndrome on lipid profile: a meta-regression analysis. J Clin Sleep Med. 2014;10(5):475–489.
263. Cao Z, Zhang P, He Z, et al. Obstructive sleep apnea combined dyslipidemia render additive effect on increasing atherosclerotic cardiovascular diseases prevalence. Lipids Health Dis. 2016;15(1):98.
264. Gruber A, Horwood F, Sithole J, Ali NJ, Idris I. Obstructive sleep apnoea is independently associated with the metabolic syndrome but not insulin resistance state. Cardiovasc Diabetol. 2006;5:22.
265. Lam JC, Lam B, Lam CL, et al. Obstructive sleep apnea and the metabolic syndrome in community-based Chinese adults in Hong Kong. Respir Med. 2006;100(6):980–987.
266. Sasanabe R, Banno K, Otake K, et al. Metabolic syndrome in Japanese patients with obstructive sleep apnea syndrome. Hypertens Res. 2006;29(5):315–322.
267. Barreiro B, Garcia L, Lozano L, et al. Obstructive sleep apnea and metabolic syndrome in Spanish population. Open Respir Med J. 2013;7:71–76.
268. Minoguchi K, Yokoe T, Tazaki T, et al. Increased carotid intima-media thickness and serum inflammatory markers in obstructive sleep apnea. Am J Respir Crit Care Med. 2005;172(5):625–630.
269. Jelic S, Bartels MN, Mateika JH, Ngai P, DeMeersman RE, Basner RC. Arterial stiffness increases during obstructive sleep apneas. Sleep. 2002;25(8):850–855.
270. Drakatos P, Higgins S, Pengo MF, et al. Derived arterial stiffness is increased in patients with obstructive sleep apnea and periodic limb movements during sleep. J Clin Sleep Med. 2016;12(2):195–202.
271. Seetho IW, Parker RJ, Craig S, Duffy N, Hardy KJ, Wilding JP. Obstructive sleep apnea is associated with increased arterial stiffness in severe obesity. J Sleep Res. 2014;23(6):700–708.
272. Gottlieb DJ, Yenokyan G, Newman AB, et al. Prospective study of obstructive sleep apnea and incident coronary heart disease and heart failure: the sleep heart health study. Circulation. 2010;122(4): 352–360.
273. Punjabi NM, Caffo BS, Goodwin JL, et al. Sleep-disordered breathing and mortality: a prospective cohort study. PLoS Med. 2009;6(8):e1000132.
274. Redline S, Yenokyan G, Gottlieb DJ, et al. Obstructive sleep apneahypopnea and incident stroke: the sleep heart health study. Am J Respir Crit Care Med. 2010;182(2):269–277.
275. Gami AS, Olson EJ, Shen WK, et al. Obstructive sleep apnea and the risk of sudden cardiac death: a longitudinal study of 10,701 adults. J Am Coll Cardiol. 2013;62(7):610–616.
276. Dayyat E, Kheirandish-Gozal L, Gozal D. Childhood obstructive sleep apnea: one or two distinct disease entities? Sleep Med Clin. 2007;2(3):433–444.
277. Wang JH, Chung YS, Cho YW, et al. Palatine tonsil size in obese, overweight, and normal-weight children with sleep-disordered breathing. Otolaryngol Head Neck Surg. 2010;142(4):516–519.
278. Spilsbury JC, Storfer-Isser A, Rosen CL, Redline S. Remission and incidence of obstructive sleep apnea from middle childhood to late adolescence. Sleep. 2015;38(1):23–29.
279. Redline S, Tishler PV, Schluchter M, Aylor J, Clark K, Graham G. Risk factors for sleep-disordered breathing in children. Associations with obesity, race, and respiratory problems. Am J Respir Crit Care Med. 1999;159(5 pt 1):1527–1532.
280. Rudnick EF, Walsh JS, Hampton MC, Mitchell RB. Prevalence and ethnicity of sleep-disordered breathing and obesity in children. Otolaryngol Head Neck Surg. 2007;137(6):878–882.
281. Xu Z, Jiaqing A, Yuchuan L, Shen K. A case-control study of obstructive sleep apnea-hypopnea syndrome in obese and nonobese Chinese children. Chest. 2008;133(3):684–689.
282. Alonso-Alvarez ML, Cordero-Guevara JA, Teran-Santos J, et al. Obstructive sleep apnea in obese community-dwelling children: the NANOS study. Sleep. 2014;37(5):943–949.
283. Canapari CA, Hoppin AG, Kinane TB, Thomas BJ, Torriani M, Katz ES. Relationship between sleep apnea, fat distribution, and insulin resistance in obese children. J Clin Sleep Med. 2011;7(3):268–273.
284. Kohler MJ, Thormaehlen S, Kennedy JD, et al. Differences in the association between obesity and obstructive sleep apnea among children and adolescents. J Clin Sleep Med. 2009;5(6):506–511.
285. Kaditis AG, Alexopoulos EI, Hatzi F, et al. Adiposity in relation to age as predictor of severity of sleep apnea in children with snoring. Sleep Breath. 2008;12(1):25–31.
286. Kalra M, Inge T, Garcia V, et al. Obstructive sleep apnea in extremely overweight adolescents undergoing bariatric surgery. Obes Res. 2005;13(7):1175–1179.
287. Kaditis AG, Alexopoulos EI, Damani E, et al. Obstructive sleepdisordered breathing and fasting insulin levels in nonobese children. Pediatr Pulmonol. 2005;40(6):515–523.
288. Tauman R, O’Brien LM, Ivanenko A, Gozal D. Obesity rather than severity of sleep-disordered breathing as the major determinant of insulin resistance and altered lipidemia in snoring children. Pediatrics. 2005;116(1):e66–e73.
289. Gozal D, Capdevila OS, Kheirandish-Gozal L. Metabolic alterations and systemic inflammation in obstructive sleep apnea among nonobese and obese prepubertal children. Am J Respir Crit Care Med. 2008;177(10):1142–1149.
290. Li AM, Chan MH, Chan DF, et al. Insulin and obstructive sleep apnea in obese Chinese children. Pediatr Pulmonol. 2006;41(12):1175–1181.
291. Hannon TS, Lee S, Chakravorty S, Lin YAN, Arslanian SA. Sleepdisordered breathing in obese adolescents is associated with visceral adiposity and markers of insulin resistance. Int J Pediatr Obes. 2011;6(2):157–160.
292. de la Eva RC, Baur LA, Donaghue KC, Waters KA. Metabolic correlates with obstructive sleep apnea in obese subjects. J Pediatr. 2002;140(6):654–659.
293. Redline S, Storfer-Isser A, Rosen CL, et al. Association between metabolic syndrome and sleep-disordered breathing in adolescents. Am J Respir Crit Care Med. 2007;176(4):401–408.
294. Lesser DJ, Bhatia R, Tran WH, et al. Sleep fragmentation and intermittent hypoxemia are associated with decreased insulin sensitivity in obese adolescent Latino males. Pediatr Res. 2012;72(3):293–298.
295. Kelly A, Dougherty S, Cucchiara A, Marcus CL, Brooks LJ. Catecholamines, adiponectin, and insulin resistance as measured by HOMA in children with obstructive sleep apnea. Sleep. 2010;33(9): 1185–1191.
296. Bhushan B, Maddalozzo J, Sheldon SH, et al. Metabolic alterations in children with obstructive sleep apnea. Int J Pediatr Otorhinolaryngol. 2014;78(5):854–859.
297. Shamsuzzaman A, Szczesniak RD, Fenchel MC, Amin RS. Glucose, insulin, and insulin resistance in normal-weight, overweight and obese children with obstructive sleep apnea. Obes Res Clin Pract. 2014; 8(6):e584–e591.
298. Koren D, Gozal D, Bhattacharjee R, Philby M, Kheirandish-Gozal L. Impact of adenotonsillectomy on insulin resistance and lipoprotein profile in nonobese and obese children. Chest. 2016;149(4):999–1010.
299. Waters KA, Sitha S, O’Brien LM, et al. Follow-up on metabolic markers in children treated for obstructive sleep apnea. Am J Respir Crit Care Med. 2006;174(4):455–460.
300. Bhushan B, Ayub B, Loghmanee DA, Billings KR. Metabolic alterations in adolescents with obstructive sleep apnea. Int J Pediatr Otorhinolaryngol. 2015;79(12):2368–2373.
301. Shalitin S, Tauman R, Meyerovitch J, Sivan Y. Are frequency and severity of sleep-disordered breathing in obese children and youth with and without type 2 diabetes mellitus different? Acta Diabetol. 2014;51(5):757–764.
302. Kaditis AG, Alexopoulos EI, Kostadima E, et al. Comparison of blood pressure measurements in children with and without habitual snoring. Pediatr Pulmonol. 2005;39(5):408–414.
303. Amin RS, Carroll JL, Jeffries JL, et al. Twenty-four–hour ambulatory blood pressure in children with sleep-disordered breathing. Am J Respir Crit Care Med. 2004;169(8):950–956.
304. Leung LC, Ng DK, Lau MW, et al. Twenty-four-hour ambulatory BP in snoring children with obstructive sleep apnea syndrome. Chest. 2006;130(4):1009–1017.
305. Enright PL, Goodwin JL, Sherrill DL, Quan JR, Quan SF; Tucson Children’s Assessment of Sleep Apnea Study. Blood pressure elevation associated with sleep-related breathing disorder in a community sample of white and Hispanic children: the Tucson Children’s Assessment of Sleep Apnea study. Arch Pediatr Adolesc Med. 2003;157(9):901–904.
306. Li AM, Au CT, Sung RY, et al. Ambulatory blood pressure in children with obstructive sleep apnoea – a community based study. Thorax. 2008;63(9):803–809.
307. Marcus CL, Greene MG, Carroll JL. Blood pressure in children with obstructive sleep apnea. Am J Respir Crit Care Med. 1998;157(4 pt 1): 1098–1103.
308. Ng DK, Wong JC, Chan CH, Leung LC, Leung SY. Ambulatory blood pressure before and after adenotonsillectomy in children with obstructive sleep apnea. Sleep Med. 2010;11(7):721–725.
309. Apostolidou MT, Alexopoulos EI, Damani E, et al. Absence of blood pressure, metabolic, and inflammatory marker changes after adenotonsillectomy for sleep apnea in Greek children. Pediatr Pulmonol. 2008;43(6):550–560.
310. Quante M, Wang R, Weng J, et al; Childhood Adenotonsillectomy Trial (CHAT). The effect of adenotonsillectomy for childhood sleep apnea on cardiometabolic measures. Sleep. 2015;38(9):1395–1403.
311. Suri JC, Sen MK, Sharma R, Chakrabarti S, Mir E, Adhikari T. Metabolic changes in normal- and underweight children with obstructive sleep-disordered breathing. Sleep Med. 2015;16(11):1366–1371.
312. Alexopoulos EI, Gletsou E, Kostadima E, et al. Effects of obstructive sleep apnea severity on serum lipid levels in Greek children with snoring. Sleep Breath. 2011;15(4):625–631.
313. Nakra N, Bhargava S, Dzuira J, Caprio S, Bazzy-Asaad A. Sleepdisordered breathing in children with metabolic syndrome: the role of leptin and sympathetic nervous system activity and the effect of continuous positive airway pressure. Pediatrics. 2008;122(3): e634–e642.
314. Verhulst SL, Schrauwen N, Haentjens D, et al. Sleep-disordered breathing and the metabolic syndrome in overweight and obese children and adolescents. J Pediatr. 2007;150(6):608–612.
315. Jalilolghadr S, Yazdi Z, Mahram M, et al. Sleep architecture and obstructive sleep apnea in obese children with and without metabolic syndrome: a case control study. Sleep Breath. 2016;20(2):845–851.
316. Xu S, Wan Y, Xu M, et al. The association between obstructive sleep apnea and metabolic syndrome: a systematic review and meta-analysis. BMC Pulm Med. 2015;15:105.
317. Erdim I, Akcay T, Yilmazer R, Erdur O, Kayhan FT. Is metabolic syndrome associated with obstructive sleep apnea in obese adolescents? J Clin Sleep Med. 2015;11(12):1371–1376.
318. Freedman DS, Khan LK, Dietz WH, Srinivasan SR, Berenson GS. Relationship of childhood obesity to coronary heart disease risk factors in adulthood: the Bogalusa Heart Study. Pediatrics. 2001;108(3):712–718.
319. Tounian P, Aggoun Y, Dubern B, et al. Presence of increased stiffness of the common carotid artery and endothelial dysfunction in severely obese children: a prospective study. Lancet. 2001;358(9291):1400–1404.
320. Meyer AA, Kundt G, Steiner M, Schuff-Werner P, Kienast W. Impaired flow-mediated vasodilation, carotid artery intima-media thickening, and elevated endothelial plasma markers in obese children: the impact of cardiovascular risk factors. Pediatrics. 2006;117(5):1560–1567.
321. Iannuzzi A, Licenziati MR, Vacca M, et al. Comparison of two diets of varying glycemic index on carotid subclinical atherosclerosis in obese children. Heart Vessels. 2009;24(6):419–424.
322. Iannuzzi A, Licenziati MR, Acampora C, et al. Increased carotid intima-media thickness and stiffness in obese children. Diabetes Care. 2004;27(10):2506–2508.
323. Urbina EM, Kimball TR, McCoy CE, Khoury PR, Daniels SR, Dolan LM. Youth with obesity and obesity-related type 2 diabetes mellitus demonstrate abnormalities in carotid structure and function. Circulation. 2009;119(22):2913–2919.
324. Gozal D, Kheirandish-Gozal L, Bhattacharjee R, Spruyt K. Neurocognitive and endothelial dysfunction in children with obstructive sleep apnea. Pediatrics. 2010;126(5):e1161–e1167.
325. Gozal D, Kheirandish-Gozal L, Serpero LD, Sans Capdevila O, Dayyat E. Obstructive sleep apnea and endothelial function in schoolaged nonobese children: effect of adenotonsillectomy. Circulation. 2007;116(20):2307–2314.
326. Bhattacharjee R, Kim J, Alotaibi WH, Kheirandish-Gozal L, Capdevila OS, Gozal D. Endothelial dysfunction in children without hypertension: potential contributions of obesity and obstructive sleep apnea. Chest. 2012;141(3):682–691.
327. Dubern B, Aggoun Y, Boule M, Fauroux B, Bonnet D, Tounian P. Arterial alterations in severely obese children with obstructive sleep apnoea. Int J Pediatr Obes. 2010;5(3):230–236.
328. Iannuzzi A, Licenziati MR, De Michele F, et al. C-reactive protein and carotid intima-media thickness in children with sleep disordered breathing. J Clin Sleep Med. 2013;9(5):493–498.
329. Koren D, Chirinos JA, Katz LE, et al. Interrelationships between obesity, obstructive sleep apnea syndrome and cardiovascular risk in obese adolescents. Int J Obes (Lond). 2015;39(7):1086–1093.
330. Ciftel M, Demir B, Kozan G, Yilmaz O, Kahveci H, Kilic O. Evaluation of carotid intima-media thickness and carotid arterial stiffness in children with adenotonsillar hypertrophy. World J Pediatr. 2016;12(1):103–108.
331. Indra N, Brian M, Suhail A-S, et al. Obstructive sleep apnea and vascular stiffness in obese adolescents. In: A27. Advances in Pediatric Sleep; American Thoracic Society; 2016:A1221–A1221; San Francisco, CA.
332. Tal A, Leiberman A, Margulis G, Sofer S. Ventricular dysfunction in children with obstructive sleep apnea: radionuclide assessment. Pediatr Pulmonol. 1988;4(3):139–143.
333. Spath-Schwalbe E, Gofferje M, Kern W, Born J, Fehm HL. Sleep disruption alters nocturnal ACTH and cortisol secretory patterns. Biol Psychiatry. 1991;29(6):575–584.
334. Buckley TM, Schatzberg AF. On the interactions of the hypothalamicpituitary-adrenal (HPA) axis and sleep: normal HPA axis activity and circadian rhythm, exemplary sleep disorders. J Clin Endocrinol Metab. 2005;90(5):3106–3114.
335. Shamsuzzaman AS, Winnicki M, Lanfranchi P, et al. Elevated C-reactive protein in patients with obstructive sleep apnea. Circulation. 2002;105(21):2462–2464.
336. Yokoe T, Minoguchi K, Matsuo H, et al. Elevated levels of C-reactive protein and interleukin-6 in patients with obstructive sleep apnea syndrome are decreased by nasal continuous positive airway pressure. Circulation. 2003;107(8):1129–1134.
337. Nadeem R, Molnar J, Madbouly EM, et al. Serum inflammatory markers in obstructive sleep apnea: a meta-analysis. J Clin Sleep Med. 2013;9(10):1003–1012.
338. Drager LF, Lopes HF, Maki-Nunes C, et al. The impact of obstructive sleep apnea on metabolic and inflammatory markers in consecutive patients with metabolic syndrome. PLoS One. 2010;5(8):e12065.
339. Sharma S, Malur A, Marshall I, et al. Alveolar macrophage activation in obese patients with obstructive sleep apnea. Surgery. 2012;151(1):107–112.
340. Baessler A, Nadeem R, Harvey M, et al. Treatment for sleep apnea by continuous positive airway pressure improves levels of inflammatory markers – a meta-analysis. J Inflamm (Lond). 2013;10:13.
341. Vgontzas AN, Zoumakis E, Bixler EO, et al. Selective effects of CPAP on sleep apnoea-associated manifestations. Eur J Clin Invest. 2008;38(8):585–595.
342. Schwab RJ, Pasirstein M, Pierson R, et al. Identification of upper airway anatomic risk factors for obstructive sleep apnea with volumetric magnetic resonance imaging. Am J Respir Crit Care Med. 2003;168(5):522–530.
343. Pillar G, Shehadeh N. Abdominal fat and sleep apnea: the chicken or the egg? Diabetes Care. 2008;31(suppl 2):S303–S309.
344. Naimark A, Cherniack RM. Compliance of the respiratory system and its components in health and obesity. J Appl Physiol. 1960;15: 377–382.
345. Sakurai S, Nishijima T, Takahashi S, Yamauchi K, Arihara Z, Takahashi K. Low plasma orexin-A levels were improved by continuous positive airway pressure treatment in patients with severe obstructive sleep apnea-hypopnea syndrome. Chest. 2005;127(3):731–737.
346. Harsch IA, Konturek PC, Koebnick C, et al. Leptin and ghrelin levels in patients with obstructive sleep apnoea: effect of CPAP treatment. Eur Resp J. 2003;22.
347. Phillips BG, Kato M, Narkiewicz K, Choe I, Somers VK. Increases in leptin levels, sympathetic drive, and weight gain in obstructive sleep apnea. Am J Physiol Heart Circ Physiol. 2000;279(1):H234–237.
348. Tachikawa R, Ikeda K, Minami T, et al. Changes in energy metabolism after continuous positive airway pressure for obstructive sleep apnea. Am J Respir Crit Care Med. Epub 2016 Mar 1.
349. Munzer T, Hegglin A, Stannek T, et al. Effects of long-term continuous positive airway pressure on body composition and IGF1. Eur J Endocrinol. 2010;162(4):695–704.
350. Batool-Anwar S, Goodwin JL, Drescher AA, et al. Impact of CPAP on activity patterns and diet in patients with obstructive sleep apnea (OSA). J Clin Sleep Med. 2014;10(5):465–472.
351. Iiyori N, Alonso LC, Li J, et al. Intermittent hypoxia causes insulin resistance in lean mice independent of autonomic activity. Am J Respir Crit Care Med. 2007;175(8):851–857.
352. Stamatakis KA, Punjabi NM. Effects of sleep fragmentation on glucose metabolism in normal subjects. Chest. 2010;137(1):95–101.
353. Marcus CL, Brooks LJ, Draper KA, et al; American Academy of Pediatrics. Diagnosis and management of childhood obstructive sleep apnea syndrome. Pediatrics. 2012;130(3):e714–e755.
354. Tauman R, O’Brien LM, Gozal D. Hypoxemia and obesity modulate plasma C-reactive protein and interleukin-6 levels in sleep-disordered breathing. Sleep Breath. 2007;11(2):77–84.
355. O’Brien LM, Gozal D. Autonomic dysfunction in children with sleepdisordered breathing. Sleep. 2005;28(6):747–752.
356. Tauman R, Serpero LD, Capdevila OS, et al. Adipokines in children with sleep disordered breathing. Sleep. 2007;30(4):443–449.
357. Oltmanns KM, Gehring H, Rudolf S, et al. Hypoxia Causes Glucose Intolerance in Humans. Am J Respir Crit Care Med. 2004;169(11):1231–1237.
358. Brooks B, Cistulli PA, Borkman M, et al. Obstructive sleep apnea in obese noninsulin-dependent diabetic patients: effect of continuous positive airway pressure treatment on insulin responsiveness. J Clin Endocrinol Metab. 1994;79(6):1681–1685.
359. Lam JCM, Xu A, Tam S, et al. Hypoadiponectinemia is related to sympathetic activation and severity of obstructive sleep apnea. Sleep. 2008;31(12):1721–1727.
360. Martinez-Ceron E, Barquiel B, Bezos AM, et al. Effect of CPAP on glycemic control in patients with obstructive sleep apnea and type 2 diabetes. a randomized clinical trial. Am J Resp Crit Care Med. 2016.
361. Monneret D, Tamisier R, Ducros V, et al. Glucose tolerance and cardiovascular risk biomarkers in non-diabetic non-obese obstructive sleep apnea patients: effects of long-term continuous positive airway pressure. Resp Med. 2016;112:119–125.
362. Pamidi S, Wroblewski K, Stepien M, et al. Eight hours of nightly continuous positive airway pressure treatment of obstructive sleep apnea improves glucose metabolism in patients with prediabetes. a randomized controlled trial. Am J Resp Crit Care Med. 2015;192(1): 96–105.
363. Shaw JE, Punjabi NM, Naughton MT, et al. The effect of treatment of obstructive sleep apnea on glycemic control in type 2 diabetes. Am J Respir Crit Care Med. Epub 2016 Feb 29.
364. Fletcher EC, Miller J, Schaaf JW, Fletcher JG. Urinary catecholamines before and after tracheostomy in patients with obstructive sleep apnea and hypertension. Sleep. 1987;10(1):35–44.
365. Waradekar NV, Sinoway LI, Zwillich CW, Leuenberger UA. Influence of treatment on muscle sympathetic nerve activity in sleep apnea. Am J Respir Crit Care Med. 1996;153(4 pt 1):1333–1338.
366. Somers VK, Dyken ME, Mark AL, Abboud FM. Sympatheticnerve activity during sleep in normal subjects. N Engl J Med. 1993;328(5):303–307.
367. Somers VK, Mark AL, Zavala DC, Abboud FM. Contrasting effects of hypoxia and hypercapnia on ventilation and sympathetic activity in humans. J Appl Physiol (1985). 1989;67(5):2101–2106.
368. Di Murro A, Petramala L, Cotesta D, et al. Renin-angiotensin-aldosterone system in patients with sleep apnoea: prevalence of primary aldosteronism. J Renin Angiotensin Aldosterone Syst. 2010;11(3):165–172.
369. Calbet JA. Chronic hypoxia increases blood pressure and noradrenaline spillover in healthy humans. J Physiol. 2003;551(pt 1):379–386.
370. Foster GE, Hanly PJ, Ahmed SB, Beaudin AE, Pialoux V, Poulin MJ. Intermittent hypoxia increases arterial blood pressure in humans through a renin-angiotensin system-dependent mechanism. Hypertension. 2010;56(3):369–377.
371. Becker HF, Jerrentrup A, Ploch T, et al. Effect of nasal continuous positive airway pressure treatment on blood pressure in patients with obstructive sleep apnea. Circulation. 2003;107(1):68–73.
372. Hoyos CM, Yee BJ, Wong KK, Grunstein RR, Phillips CL. Treatment of sleep apnea with CPAP lowers central and peripheral blood pressure independent of the time-of-day: a randomized controlled study. Am J Hypertens. 2015;28(10):1222–1228.
373. Kario K. Obstructive sleep apnea syndrome and hypertension: mechanism of the linkage and 24-h blood pressure control. Hypertens Res. 2009;32(7):537–541.
374. Faccenda JF, Mackay TW, Boon NA, Douglas NJ. Randomized placebo-controlled trial of continuous positive airway pressure on blood pressure in the sleep apnea-hypopnea syndrome. Am J Respir Crit Care Med. 2001;163(2):344–348.
375. Li J, Thorne LN, Punjabi NM, et al. Intermittent hypoxia induces hyperlipidemia in lean mice. Circ Res. 2005;97(7):698–706.
376. Li J, Savransky V, Nanayakkara A, Smith PL, O’Donnell CP, Polotsky VY. Hyperlipidemia and lipid peroxidation are dependent on the severity of chronic intermittent hypoxia. J Appl Physiol (1985). 2007;102(2):557–563.
377. Li J, Grigoryev DN, Ye SQ, et al. Chronic intermittent hypoxia upregulates genes of lipid biosynthesis in obese mice. J Appl Physiol (1985). 2005;99(5):1643–1648.
378. Savransky V, Nanayakkara A, Li J, et al. Chronic intermittent hypoxia induces atherosclerosis. Am J Respir Crit Care Med. 2007;175(12): 1290–1297.
379. Lavie L. Oxidative stress inflammation and endothelial dysfunction in obstructive sleep apnea. Front Biosci (Elite Ed). 2012;4:1391–1403.
380. Adedayo AM, Olafiranye O, Smith D, et al. Obstructive sleep apnea and dyslipidemia: evidence and underlying mechanism. Sleep Breath. 2014;18(1):13–18.
381. Mirrakhimov AE, Ali AM. Pathobiology of obstructive sleep apnea-related dyslipidemia: focus on the liver. ISRN Cardiol. 2013; 2013:687069.
382. Barcelo A, Pierola J, de la Pena M, et al. Free fatty acids and the metabolic syndrome in patients with obstructive sleep apnoea. Eur Respir J. 2011;37(6):1418–1423.
383. Jun JC, Drager LF, Najjar SS, et al. Effects of sleep apnea on nocturnal free fatty acids in subjects with heart failure. Sleep. 2011; 34(9):1207–1213.
384. Jun JC, Shin MK, Yao Q, et al. Acute hypoxia induces hypertriglyceridemia by decreasing plasma triglyceride clearance in mice. Am J Physiol Endocrinol Metab. 2012;303(3):E377–E388.
385. Keenan BT, Maislin G, Sunwoo BY, et al. Obstructive sleep apnoea treatment and fasting lipids: a comparative effectiveness study. Eur Respir J. 2014;44(2):405–414.
386. Sharma SK, Agrawal S, Damodaran D, et al. CPAP for the metabolic syndrome in patients with obstructive sleep apnea. N Engl J Med. 2011;365(24):2277–2286.
387. Kato M, Roberts-Thomson P, Phillips BG, et al. Impairment of endothelium-dependent vasodilation of resistance vessels in patients with obstructive sleep apnea. Circulation. 2000;102(21):2607–2610.
388. Kraiczi H, Caidahl K, Samuelsson A, Peker Y, Hedner J. Impairment of vascular endothelial function and left ventricular filling: association with the severity of apnea-induced hypoxemia during sleep. Chest. 2001;119(4):1085–1091.
389. Imadojemu VA, Gleeson K, Quraishi SA, Kunselman AR, Sinoway LI, Leuenberger UA. Impaired vasodilator responses in obstructive sleep apnea are improved with continuous positive airway pressure therapy. Am J Respir Crit Care Med. 2002;165(7):950–953.
390. Ip MSM, Tse H-F, Lam B, Tsang KWT, Lam W-K. Endothelial function in obstructive sleep apnea and response to treatment. Am J Respir Crit Care Med. 2004;169(3):348–353.
391. Kohler M, Stoewhas AC, Ayers L, et al. Effects of continuous positive airway pressure therapy withdrawal in patients with obstructive sleep apnea: a randomized controlled trial. Am J Respir Crit Care Med. 2011;184(10):1192–1199.
392. Dyugovskaya L, Lavie P, Lavie L. Lymphocyte activation as a possible measure of atherosclerotic risk in patients with sleep apnea. Ann N Y Acad Sci. 2005;1051:340–350.
393. Yun C-H, Jung K-H, Chu K, et al. Increased circulating endothelial microparticles and carotid atherosclerosis in obstructive sleep apnea. J Clin Neurol. 2010;6(2):89–98.
394. Jose MM, Teresa M, Victoria G, Pablo C, Marta F, Ana LS. Long-term effect of CPAP on subclinical atherosclerosis in obstructive sleep apnea. In: D98. After Serve-HF: Now What? American Thoracic Society; 2016:A7534–A7534; San Francisco, CA.
395. Chami HA, Vasan RS, Larson MG, Benjamin EJ, Mitchell GF, Gottlieb DJ. The association between sleep-disordered breathing and aortic stiffness in a community cohort. Sleep Med. 2016;19:69–74.
396. Drager LF, Bortolotto LA, Figueiredo AC, Krieger EM, Lorenzi GF. Effects of continuous positive airway pressure on early signs of atherosclerosis in obstructive sleep apnea. Am J Respir Crit Care Med. 2007;176(7):706–712.
397. Buchner NJ, Quack I, Stegbauer J, Woznowski M, Kaufmann A, Rump LC. Treatment of obstructive sleep apnea reduces arterial stiffness. Sleep Breath. 2012;16(1):123–133.
398. Vlachantoni IT, Dikaiakou E, Antonopoulos CN, Stefanadis C, Daskalopoulou SS, Petridou ET. Effects of continuous positive airway pressure (CPAP) treatment for obstructive sleep apnea in arterial stiffness: a meta-analysis. Sleep Med Rev. 2013;17(1): 19–28.
399. Lin X, Chen G, Qi J, Chen X, Zhao J, Lin Q. Effect of continuous positive airway pressure on arterial stiffness in patients with obstructive sleep apnea and hypertension: a meta-analysis. Eur Arch Otorhinolaryngol. Epub 2016 Feb 9:1–8.
400. Shiina K, Tomiyama H, Takata Y, et al. Effects of CPAP therapy on the sympathovagal balance and arterial stiffness in obstructive sleep apnea. Respir Med. 2010;104(6):911–916.
401. Peker Y, Carlson J, Hedner J. Increased incidence of coronary artery disease in sleep apnoea: a long-term follow-up. Eur Respir J. 2006;28(3):596–602.
402. Milleron O, Pilliere R, Foucher A, et al. Benefits of obstructive sleep apnoea treatment in coronary artery disease: a long-term follow-up study. Eur Heart J. 2004;25(9):728–734.
403. Somers VK, White DP, Amin R, et al. Sleep Apnea and Cardiovascular Disease: an American Heart Association/American College of Cardiology Foundation Scientific Statement From the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology, Stroke Council, and Council on Cardiovascular Nursing in Collaboration With the National Heart, Lung, and Blood Institute National Center on Sleep Disorders Research (National Institutes of Health). Circulation. 2008;118(10): 1080–1111.
404. Marcus CL, Moore RH, Rosen CL, et al; Childhood Adenotonsillectomy Trial (CHAT). A randomized trial of adenotonsillectomy for childhood sleep apnea. N Engl J Med. 2013;368(25):2366–2376.
405. Nakra N, Bhargava S, Dzuira J, Caprio S, Bazzy-Asaad A. Sleepdisordered breathing in children with metabolic syndrome: the role of leptin and sympathetic nervous system activity and the effect of continuous positive airway pressure. Pediatrics. 2008;122(3): e634–642.
406. Karalok ZS, Akdag M, Turhan M, et al. Leptin and ghrelin levels in children before and after adenoidectomy or adenotonsillectomy. Horm Res Paediatr. 2014;81(1):20–24.
407. Salman N, Ozturk G, Akin I, Kilicaslan S, Demirel F, Delibas N. The effect of adenotonsilectomy on ghrelin, leptin, IGF-1 levels and growth parameters in children with adenotonsillar hypertrophy. J Pediatr Endocrinol Metab. 2014;27(9–10):885–890.
408. Katz ES, Moore RH, Rosen CL, et al. Growth after adenotonsillectomy for obstructive sleep apnea: an RCT. Pediatrics. 2014;134(2): 282–289.
409. Levi J, Leoniak S, Schmidt R. Evaluating tonsillectomy as a risk factor for childhood obesity. Arch Otolaryngol Head Neck Surg. 2012;138(10):897–901.
410. Deboer MD, Mendoza JP, Liu L, Ford G, Yu PL, Gaston BM. Increased systemic inflammation overnight correlates with insulin resistance among children evaluated for obstructive sleep apnea. Sleep Breath. 2012;16(2):349–354.
411. Gozal D. Sleep, sleep disorders and inflammation in children. Sleep Med. 2009;10(suppl 1):S12–S16.
412. Hakim F, Gozal D, Kheirandish-Gozal L. Sympathetic and catecholaminergic alterations in sleep apnea with particular emphasis on children. Front Neurol. 2012;3:7.
413. Aljadeff G, Gozal D, Schechtman VL, Burrell B, Harper RM, Ward SL. Heart rate variability in children with obstructive sleep apnea. Sleep. 1997;20(2):151–157.
414. Lafortuna CL, Adorni F, Agosti F, et al. Prevalence of the metabolic syndrome among extremely obese adolescents in Italy and Germany. Diabetes Res Clin Pract. 2010;88(1):14–21.
415. Gozal D, Hakim F, Kheirandish-Gozal L. Chemoreceptors, baroreceptors, and autonomic deregulation in children with obstructive sleep apnea. Respir Physiol Neurobiol. 2013;185(1):177–185.
416. Gozal D, Capdevila OS, Kheirandish-Gozal L. Metabolic alterations and systemic inflammation in obstructive sleep apnea among nonobese and obese prepubertal children. Am J Respir Crit Care Med. 2008;177(10):1142–1149.
417. Kuo YL, Kang KT, Chiu SN, Weng WC, Lee PL, Hsu WC. Blood pressure after surgery among obese and nonobese children with obstructive sleep apnea. Otolaryngol Head Neck Surg. 2015;152(5):931–940.
418. Gozal D, Serpero LD, Sans Capdevila O, Kheirandish-Gozal L. Systemic inflammation in non-obese children with obstructive sleep apnea. Sleep Med. 2008;9(3):254–259.
419. Kheirandish-Gozal L, Gileles-Hillel A, Alonso-Alvarez ML, et al. Effects of adenotonsillectomy on plasma inflammatory biomarkers in obese children with obstructive sleep apnea: a community-based study. Int J Obes (Lond). 2015;39(7):1094–1100.
420. Nachalon Y, Lowenthal N, Greenberg-Dotan S, Goldbart AD. Inflammation and growth in young children with obstructive sleep apnea syndrome before and after adenotonsillectomy. Mediators Inflamm. 2014;2014:146893.
421. Kheirandish-Gozal L, Bhattacharjee R, Kim J, Clair HB, Gozal D. Endothelial progenitor cells and vascular dysfunction in children with obstructive sleep apnea. Am J Respir Crit Care Med. 2010;182(1):92–97.
422. Abdelnaby K, Leila K-G, Maria Luz A-A, Joaquin T-S, David G. Plasma-derived exosomes alter endothelial tight junction in obese children with obstructive sleep apnea: effect of adenotonsillectomy (T&A). In: B26. Pediatric Sleep: From the Heart to the Brain; American Thoracic Society; 2015:A2596–A2596; Denver, CO.
423. Kheirandish-Gozal L, Etzioni T, Bhattacharjee R, et al. Obstructive sleep apnea in children is associated with severity-dependent deterioration in overnight endothelial function. Sleep Med. 2013;14(6):526–531.
424. Ruger M, Scheer FA. Effects of circadian disruption on the cardiometabolic system. Rev Endocr Metab Disord. 2009;10(4): 245–260.
425. Morris CJ, Aeschbach D, Scheer FAJL. Circadian system, sleep and endocrinology. Mol Cell Endocrinol. 2012;349(1):91–104.
426. Reutrakul S, Van Cauter E. Interactions between sleep, circadian function, and glucose metabolism: implications for risk and severity of diabetes. Ann N Y Acad Sci. 2014;1311:151–173.
427. Morris CJ, Yang JN, Scheer FA. The impact of the circadian timing system on cardiovascular and metabolic function. Prog Brain Res. 2012;199:337–358.
428. Karlsson B, Knutsson A, Lindahl B. Is there an association between shift work and having a metabolic syndrome? Results from a population based study of 27,485 people. Occup Environ Med. 2001;58(11): 747–752.
429. Lund J, Arendt J, Hampton SM, English J, Morgan LM. Postprandial hormone and metabolic responses among shift workers in Antarctica. J Endocrinol. 2001;171:557–564.
430. Morikawa Y, Nakagawa H, Miura K, et al. Shift work and the risk of diabetes mellitus among Japanese male factory workers. Scand J Work Environ Health. 2005;31(3):179–183.
431. Kroenke CH, Spiegelman D, Manson J, Schernhammer ES, Colditz GA, Kawachi I. Work characteristics and incidence of type 2 diabetes in women. Am J Epidemiol. 2007;165(2):175–183.
432. Knutsson A, Akerstedt T, Jonsson BG, Orth-Gomer K. Increased risk of ischaemic heart disease in shift workers. Lancet. 1986;2(8498): 89–92.
433. Merikanto I, Lahti T, Puolijoki H, et al. Associations of chronotype and sleep with cardiovascular diseases and type 2 diabetes. Chronobiol Int. 2013;30(4):470–477.
434. Reutrakul S, Hood MM, Crowley SJ, et al. Chronotype is independently associated with glycemic control in type 2 diabetes. Diabetes Care. 2013;36(9):2523–2529.
435. Lucassen EA, Zhao X, Rother KI, et al; Sleep Extension Study Group. Evening chronotype is associated with changes in eating behavior, more sleep apnea, and increased stress hormones in short sleeping obese individuals. PLoS One. 2013;8(3):e56519.
436. Arora T, Taheri S. Associations among late chronotype, body mass index and dietary behaviors in young adolescents. Int J Obes (Lond). 2015;39(1):39–44.
437. Fleig D, Randler C. Association between chronotype and diet in adolescents based on food logs. Eat Behav. 2009;10(2):115–118.
438. Salgado-Delgado R, Angeles-Castellanos M, Buijs MR, Escobar C. Internal desynchronization in a model of night-work by forced activity in rats. Neuroscience. 2008;154(3):922–931.
439. Arble D, Bass J, Laposky AD, Vitaterna MH, Turek FW. Circadian timing of food intake contributes to weight gain. Obesity (Silver Spring). 2009;17(11):2100–2102.
440. Fonken LK, Workman JL, Walton JC, et al. Light at night increases body mass by shifting the time of food intake. Proc Natl Acad Sci U S A. 2010;107(43):18664–18669.
441. Turek FW, Joshu C, Kohsaka A, et al. Obesity and metabolic syndrome in circadian clock mutant mice. Science. 2005;308(5724):1043–1045.
442. Hampton SM, Morgan LM, Lawrence N, et al. Postprandial hormone and metabolic responses in simulated shift work. J Endocrinol. 1996;151(2):259–267.
443. Ribeiro D, Hampton SM, Morgan L, Deacon S, Arendt J. Altered postprandial hromone and metabolic responses in a simulated shift work environment. J Endocrinol. 1998;158:305–310.
444. Scheer FA, Hitlon MF, Mantzoros CS, Shea SA. Adverse metabolic and cardiovascular consequences of circadian misalignment. Proc Natl Acad Sci U S A. 2009;106(11):4453–4458.
445. Beebe DW, Zhou A, Rausch J, Noe O, Simon SL. The impact of early bedtimes on adolescent caloric intake varies by chronotype. J Adolesc Health. 2015;57(1):120–122.
446. Van Cauter E, Blackman JD, Roland D, Spire JP, Refetoff S, Polonsky KS. Modulation of glucose regulation and insulin secretion by circadian rhythmicity and sleep. J Clin Invest. 1991;88(3):934–942.
447. Simon C, Gronfier C, Schlienger JL, Brandenberger G. Circadian and ultradian variations of leptin in normal man under continuous enteral nutrition: relationship to sleep and body temperature. J Clin Endocrinol Metab. 1998;83(6):1893–1899.
448. Shea SA, Hilton MF, Orlova C, Ayers RT, Mantzoros CS. Independent circadian and sleep/wake regulation of adipokines and glucose in humans. J Clin Endocrinol Metab. 2005;90(5):2537–2544.
449. Roberts CK, Hevener AL, Barnard RJ. Metabolic syndrome and insulin resistance: underlying causes and modification by exercise training. Compr Physiol. 2013;3(1):1–58.
450. Zhang EE, Liu Y, Dentin R, et al. Cryptochrome mediates circadian regulation of cAMP signaling and hepatic gluconeogenesis. Nat Med. 2010;16(10):1152–1156.
451. Marcheva B, Ramsey KM, Buhr ED, et al. Disruption of the clock components CLOCK and BMAL1 leads to hypoinsulinaemia and diabetes. Nature. 2010;466(7306):627–631.